CK2 signaling in androgen-dependent and -independent prostate cancer

Guixia Wang, Kashif A. Ahmad, Gretchen Unger, Joel W. Slaton, Khalil Ahmed

Research output: Contribution to journalReview articlepeer-review

31 Scopus citations


Protein serine/threonine kinase casein kinase 2 (CK2) is a key player in cell growth and proliferation but is also a potent suppressor of apoptosis. CK2 has been found to be dysregulated in all the cancers that have been examined, including prostate cancer. Investigations of CK2 signaling in the prostate were originally initiated in this laboratory, and these studies have identified significant functional activities of CK2 in relation to normal prostate growth and to the pathobiology of androgen-dependent and -independent prostate cancer. We present a brief overview of these developments in the context of prostate biology. An important outcome of these studies is the emerging concept that CK2 can be effectively targeted for cancer therapy.

Original languageEnglish (US)
Pages (from-to)382-391
Number of pages10
JournalJournal of Cellular Biochemistry
Issue number2
StatePublished - Oct 1 2006


  • Androgen
  • Apoptosis
  • CK2 (formerly casein kinase 2)
  • Cancer
  • Chromatin
  • Growth factors
  • Nuclear matrix
  • Prostate
  • Signaling


Dive into the research topics of 'CK2 signaling in androgen-dependent and -independent prostate cancer'. Together they form a unique fingerprint.

Cite this